Stay updated on PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer
Sign up to get notified when there's something new on the PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer page.

Latest updates to the PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference3%
- Check16 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2 and the Back to Top element was removed. No core content, pricing, or time-sensitive information is affected.SummaryDifference0.2%
- Check37 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%
- Check44 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several key medical topics and terms related to pembrolizumab and prostate cancer have been removed.SummaryDifference2%
- Check58 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the PRINCE Trial: PSMA-lutetium & Immunotherapy in Prostate Cancer page.